Works matching IS 1607551X AND DT 2024 AND VI 40 AND IP 5

Results: 13
    1
    2

    NTRK3 exhibits a pro‐oncogenic function in upper tract urothelial carcinomas.

    Published in:
    Kaohsiung Journal of Medical Sciences, 2024, v. 40, n. 5, p. 445, doi. 10.1002/kjm2.12824
    By:
    • Lim, Lee‐Moay;
    • Lee, Yi‐Chen;
    • Lin, Ting‐Wei;
    • Hong, Zi‐Xuan;
    • Hsu, Wei‐Chi;
    • Ke, Hung‐Lung;
    • Hwang, Daw‐Yang;
    • Chung, Wen‐Yu;
    • Li, Wei‐Ming;
    • Lin, Hui‐Hui;
    • Kuo, Hung‐Tien;
    • Huang, A‐Mei
    Publication type:
    Article
    3
    4

    Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR‐mutated advanced non‐small‐cell lung.

    Published in:
    Kaohsiung Journal of Medical Sciences, 2024, v. 40, n. 5, p. 467, doi. 10.1002/kjm2.12822
    By:
    • Kuo, Chia‐Yu;
    • Tsai, Ming‐Ju;
    • Hung, Jen‐Yu;
    • Lee, Mei‐Hsuan;
    • Wu, Kuan‐Li;
    • Tsai, Yu‐Chen;
    • Chuang, Cheng‐Hao;
    • Huang, Chung‐Wen;
    • Chen, Chin‐Ling;
    • Yang, Chih‐Jen;
    • Chong, Inn‐Wen
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Third vaccine boosters and anti‐S‐IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma.

    Published in:
    Kaohsiung Journal of Medical Sciences, 2024, v. 40, n. 5, p. 477, doi. 10.1002/kjm2.12812
    By:
    • Wang, Chih‐Wen;
    • Huang, Chung‐Feng;
    • Jang, Tyng‐Yuan;
    • Yeh, Ming‐Lun;
    • Liang, Po‐Cheng;
    • Wei, Yu‐Ju;
    • Hsu, Po‐Yao;
    • Huang, Ching‐I.;
    • Hsieh, Ming‐Yen;
    • Lin, Yi‐Hung;
    • Huang, Jee‐Fu;
    • Dai, Chia‐Yen;
    • Chuang, Wan‐Long;
    • Yu, Ming‐Lung
    Publication type:
    Article
    12
    13

    Issue Information.

    Published in:
    Kaohsiung Journal of Medical Sciences, 2024, v. 40, n. 5, p. 417, doi. 10.1002/kjm2.12703
    Publication type:
    Article